Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

Inclusion Criteria: * Advanced Stage Endometrial Cancer (Stage 3 or 4) * Any Histology including clear cell, and serous papillary carcinomas * surgery must have had hysterectomy and bilateral salpingo-oophorectomy * chemotherapy initiated 12 weeks after surgery * sign informed consent * Adequate End-organ function * GOG (Gynecologic Oncology Group)Performance Status 0,1,2 * Patients must be 18 years or older * Patients may have received radiation for the treatment of endometrial cancer. * Patients may have measurable or non-measurable disease. Exclusion Criteria: * Patient with concomitant malignancy other than non-melanoma skin cancer * Patients with prior malignancy who have been disease free for 5 years. * Patients with serious uncontrolled infection, angina or serious peripheral neuropathy. * Patients whose circumstances will not permit study completion or adequate follow up * Patients who have received prior cytotoxic chemotherapy for treatment of endometrial cancer including chemotherapy used for radiation sensitization.